Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jun;25(6):1985-93.
doi: 10.1007/s00464-010-1499-7. Epub 2010 Dec 7.

A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer

Hyuk Lee  1 , Won Kyoung Yun, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Kyoung Mee Kim, Jong Chul Rhee, Jae J Kim
Affiliations
Comparative Study

A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer

Hyuk Lee et al. Surg Endosc. 2011 Jun.

Abstract

Background: Endoscopic submucosal dissection (ESD) is the standard treatment for selected cases of early gastric cancer (EGC). Evolution of ESD techniques and accessories has expanded treatment indications. The aim of this study was to compare the therapeutic outcomes for conventional and expanded indications of ESD for EGC.

Methods: Eight hundred six EGC lesions in 780 patients were classified into two groups based on a pathological review: a conventional indication group (595 cases) and an expanded indication group (211 cases). The expanded indication group was classified further into subgroups according to tumor depth and tumor size. Therapeutic outcomes were compared between the conventional and expanded indication groups and between the expanded indication subgroups.

Results: The complete resection rate (97.3% vs. 81.0%, p<0.001) and en bloc complete resection rate (95.6% vs. 79.1%, p=0.003) were higher in the conventional indication group than in the expanded indication group. Among the expanded indication patients, the complete resection rate (64.5% vs. 91.1%, p<0.001) and en bloc complete resection rate (63.2% vs. 89.6%, p<0.001) were lower in the submucosal invasion subgroup than in the mucosal invasion subgroup. The complete resection rate and en bloc complete resection rate did not differ between subgroups classified according to tumor size in the expanded indication group. The conventional indication group and expanded indication group did not differ with regard to the rates of local recurrence (0.7% vs. 0%), metachronous recurrence (3.6% vs. 3.3%), or cumulative disease-free survival. Survival outcome was similar in the subgroups classified by tumor depth and size. Perforation was more frequent in the expanded indication group than in the conventional indication group (6.6% vs. 2.4%, p<0.001).

Conclusion: ESD for expanded indication of EGC had acceptable clinical outcomes. ESD can be applied safely to properly selected patients with EGC.

PubMed Disclaimer

References

    1. Gastric Cancer. 2007;10(1):1-11 - PubMed
    1. Lancet. 1995 Mar 25;345(8952):745-8 - PubMed
    1. Gut. 1997 Aug;41(2):142-50 - PubMed
    1. J Gastroenterol Hepatol. 2000 Oct;15 Suppl:G49-57 - PubMed
    1. Gut. 2001 Feb;48(2):225-9 - PubMed

Publication types

LinkOut - more resources